Nautilus Biotechnology (NAUT) Non Operating Income (2020 - 2026)

Nautilus Biotechnology has disclosed Non Operating Income across 7 years of filings, most recently posting $1.4 million for Q1 2026.

• Non Operating Income for Q1 2026 came in at $1.4 million, down 36.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.0 million (down 30.03% YoY), and the FY2025 annual result was $7.8 million, down 26.74% from the prior year.
• Non Operating Income came in at $1.4 million for Q1 2026 at Nautilus Biotechnology, down from $1.6 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $3.2 million in Q2 2023 to a low of -$132000.0 in Q3 2022.
• The 5-year median for Non Operating Income is $2.4 million (2024), against an average of $2.1 million.
• Across the five-year window, Non Operating Income slumped 83.33% in 2022 and jumped 45728.57% in 2023, its largest moves.
• Nautilus Biotechnology's Non Operating Income stood at $2.9 million in 2022, then gained by 2.83% to $3.0 million in 2023, then decreased by 19.85% to $2.4 million in 2024, then plunged by 31.14% to $1.6 million in 2025, then fell by 13.15% to $1.4 million in 2026.
• The last three Non Operating Income figures came in at $1.4 million (Q1 2026), $1.6 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.